Skip to main content

Table 4 High/not high model

From: An integrative method for scoring candidate genes from association studies: application to warfarin dosing

Gene Name P-Value
VKORC1 Vitamin K1 2,3-epoxide reductase subunit 1 4.39E-06
CYP2C9 cytochrome P450, family 2, subfamily C 2.27E-04
QTRTD1 queuine tRNA-ribosyltransferase domain 3.21E-04
NAT13 N-acetyltransferase 13 5.25E-03
BAT5 HLA-B associated transcript 5 6.76E-03
CRP C-reactive protein, pentraxin-related 1.02E-02
COL1A2 Alpha-2 type I collagen 1.37E-02
GGCX Vitamin K gamma glutamyl carboxylase 1.44E-02
A2M C3 and PZP-like alpha-2-macroglobulin 2.06E-02
FBXO28 F-box protein 28 2.14E-02
HSD3B7 3-beta-HSD VII 2.54E-02
ITGA5 Fibronectin receptor subunit alpha 4.07E-02
ALS2 amyotrophic lateral sclerosis 2 4.13E-02
NSUN6 NOL1/NOP2/Sun domain family 6 4.21E-02
SORBS3 sorbin and SH3 domain containing 3 4.99E-02
  1. Top 15 genes with candidate gene-scores that significantly distinguish between high dose patients and non-high-dose patients (p≤0.05). P-Values are result of t test between low-dose and non-low-dose distributions of gene-scores. Genes in bold are significant after correcting for multiple hypothesis testing.